scispace - formally typeset
S

Sara Trabulo

Researcher at Queen Mary University of London

Publications -  26
Citations -  1559

Sara Trabulo is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Pancreatic cancer & Cancer stem cell. The author has an hindex of 18, co-authored 26 publications receiving 1314 citations. Previous affiliations of Sara Trabulo include Bayer & University of Coimbra.

Papers
More filters
Journal ArticleDOI

Cell-Penetrating Peptides—Mechanisms of Cellular Uptake and Generation of Delivery Systems

TL;DR: The current knowledge of the mechanisms responsible for the cellular uptake of cell-penetrating peptides, including the S413-PV peptide, are discussed, and the potential of peptide-based formulations to mediate nucleic acid delivery is discussed.
Journal ArticleDOI

Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

TL;DR: Targeting CD47 efficiently enhanced phagocytosis of a representative set of primary pancreatic cancer (stem) cells and also directly induced their apoptosis in the absence of macrophages during long-term inhibition of CD47 strongly suggest that CD47 inhibition could be a novel adjuvant treatment strategy for PDAC independent of underlying and highly variable driver mutations.
Journal ArticleDOI

Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells.

TL;DR: It is demonstrated that metformin selectively ablated pancreatic CSCs as evidenced by diminished expression of pluripotency-associated genes and CSC-associated surface markers, which effectively reduced tumor burden and prevented disease progression in primary cancer tissue xenograft models.
Journal ArticleDOI

Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling

TL;DR: This study demonstrates that via to date unreported effects, chloroquine is an effective adjuvant therapy to chemotherapy, offering more efficient tumor elimination and improved cure rates.
Journal ArticleDOI

The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells

TL;DR: The miR-17-92 cluster is identified as a functionally determining family of miRNAs in CSCs, and the putative potential of developing modulators of this cluster to overcome drug resistance in pancreatic C SCs is highlighted.